Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs
暂无分享,去创建一个
[1] D. M. van der Heijde,et al. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. , 2010, Arthritis and rheumatism.
[2] J. Kremer,et al. Factors Influencing Fracture Risk, T Score, and Management of Osteoporosis in Patients With Rheumatoid Arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) Registry , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[3] K. Åkesson,et al. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis , 2008, Scandinavian journal of rheumatology.
[4] G. Mundy. Osteoporosis and inflammation. , 2007, Nutrition reviews.
[5] A. Delle Sedie,et al. Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.
[6] W. Lems,et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density , 2004, Annals of the rheumatic diseases.
[7] S. Adami,et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. , 2004, The Journal of rheumatology.
[8] G. Haugeberg,et al. Effects of rheumatoid arthritis on bone , 2003, Current opinion in rheumatology.
[9] G. Haugeberg,et al. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population , 2003, Osteoporosis International.
[10] F. Taşcioğlu,et al. The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis , 2003, Rheumatology International.
[11] A. Dolan,et al. Does active treatment of rheumatoid arthritis limit disease-associated bone loss? , 2002, Rheumatology.
[12] G. Haugeberg,et al. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. , 2002, Arthritis and rheumatism.
[13] S. Sierakowski,et al. [The effect of low dose methotrexate treatment on bone mineral density in patients with rheumatoid arthritis]. , 2002, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[14] P. van Riel,et al. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. , 2001, Arthritis and rheumatism.
[15] X. Marchandise,et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. , 2000, Clinical and experimental rheumatology.
[16] G. Hein,et al. [Inflammation and bone metabolism in rheumatoid arthritis. Pathogenetic viewpoints and therapeutic possibilities]. , 1997, Medizinische Klinik.
[17] P. Vacek,et al. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. , 1997, The Journal of rheumatology.
[18] X. Marchandise,et al. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. , 1997, Revue du rhumatisme.
[19] A. Mahmoud,et al. Bone mineral density in nonsteroid treated early rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.
[20] A. Verbeek,et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. , 1993, Annals of the rheumatic diseases.
[21] S. Epstein,et al. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. , 1991, Seminars in arthritis and rheumatism.
[22] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[23] J. Pødenphant,et al. Bone loss in rheumatoid arthritis : influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment , 1996 .
[24] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.